Xbox shows how it's done: less show, more content. Sony? More trailers, less sense. Unfortunately, the real showdown is in the marketing jungle, with hope for improvement.

The best Xbox One games may seem outdated now that the current generation of consoles has succeeded it, but that doesn't mean you can't still make the most of last-generation games. That's because ...

The key is Microsoft Rewards, a loyalty program that rewards people who use Microsoft products such as Bing and Xbox. It only takes about 20 minutes a day to rack up enough points to get a free ...

Microsoft reportedly considered completely shutting down Xbox in 2021, prior to its acquisition of ZeniMax and Activision Blizzard. According to The Information, Microsoft CEO Satya Nadella ...

It takes the concept of the Union Of Light design and bombards it with ice and frost while also filling the costume with different shades of blue and white to create a design that makes Scorpion ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

2025 is finally here, and for Xbox fans, that marks another year of dualities. Microsoft is likely to have its most potent year in first-party content in history. After almost a decade of requests ...

Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...